Related references
Note: Only part of the references are listed.Targeted delivery of celastrol to glomerular endothelium and podocytes for chronic kidney disease treatment
Qingsi Wu et al.
NANO RESEARCH (2022)
Parvovirus B19 induces cellular senescence in human dermal fibroblasts: putative role in systemic sclerosis-associated fibrosis
Rosaria Arvia et al.
RHEUMATOLOGY (2022)
Insights into the knowledge of complex diseases: Environmental infectious/ toxic agents as potential etiopathogenetic factors of systemic sclerosis
Clodoveo Ferri et al.
JOURNAL OF AUTOIMMUNITY (2021)
Effect of N-terminal region of human parvovirus B19-VP1 unique region on cardiac injury in naive mice
Kuo-Chuan Hung et al.
MOLECULAR MEDICINE REPORTS (2021)
The Therapeutic Potential of Celastrol in Central Nervous System Disorders: Highlights from In Vitro and In Vivo Approaches
Stefania Schiavone et al.
MOLECULES (2021)
Biosynthesis, total synthesis, structural modifications, bioactivity, and mechanism of action of the quinone-methide triterpenoid celastrol
Yun Lu et al.
MEDICINAL RESEARCH REVIEWS (2021)
Celastrol is a novel selective agonist of cannabinoid receptor 2 with anti-inflammatory and anti-fibrotic activity in a mouse model of systemic sclerosis
Xingwu Jiang et al.
PHYTOMEDICINE (2020)
Celastrol attenuates collagen-induced arthritis via inhibiting oxidative stress in rats
Qiang Gao et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Parvovirus B19 activates in vitro normal human dermal fibroblasts: a possible implication in skin fibrosis and systemic sclerosis
Rosaria Arvia et al.
RHEUMATOLOGY (2020)
The effects of human parvovirus VP1 unique region in a mouse model of allergic asthma
Shyh-Ren Chiang et al.
PLOS ONE (2019)
Molecular modulators of celastrol as the keystones for its diverse pharmacological activities
Sin Wi Ng et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
IL-1-IL-17 Signaling Axis Contributes to Fibrosis and Inflammation in Two Different Murine Models of Systemic Sclerosis
Min-Jung Park et al.
FRONTIERS IN IMMUNOLOGY (2018)
The VP1 unique region of human parvovirus B19 and human bocavirus induce lung injury in naive Balb/c mice
Chun-Yu Lin et al.
PLOS ONE (2018)
Systemic sclerosis sine scleroderma
Eugeniusz J. Kucharz et al.
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2017)
The role of parvovirus B19 in the pathogenesis of autoimmunity and autoimmune disease
Jonathan R. Kerr
JOURNAL OF CLINICAL PATHOLOGY (2016)
Frequency and significance of parvovirus B19 infection in patients with rheumatoid arthritis
Milda Naciute et al.
JOURNAL OF GENERAL VIROLOGY (2016)
TGF-β: the master regulator of fibrosis
Xiao-ming Meng et al.
NATURE REVIEWS NEPHROLOGY (2016)
Celastrol modulates inflammation through inhibition of the catalytic activity of mediators of arachidonic acid pathway: Secretory phospholipase A2 group IIA, 5-lipoxygenase and cyclooxygenase-2
Vikram Joshi et al.
PHARMACOLOGICAL RESEARCH (2016)
Control of autoimmune inflammation by celastrol, a natural triterpenoid
Shivaprasad H. Venkatesha et al.
PATHOGENS AND DISEASE (2016)
The prevalence of infectious agents in patients with systemic sclerosis
Huseyin Bilgin et al.
TURKISH JOURNAL OF MEDICAL SCIENCES (2015)
Transforming growth factor β-at the centre of systemic sclerosis
Robert Lafyatis
NATURE REVIEWS RHEUMATOLOGY (2014)
Effects of Human Parvovirus B19 and Bocavirus VP1 Unique Region on Tight Junction of Human Airway Epithelial A549 Cells
Chun-Ching Chiu et al.
PLOS ONE (2014)
Significant association of past parvovirus B19 infection with cytopenia in both adult-onset Still's disease and systemic lupus erythematosus patients
Der-Yuan Chen et al.
CLINICA CHIMICA ACTA (2012)
The Pathogenesis of Systemic Sclerosis
Tamiko R. Katsumoto et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 6 (2011)
Phospholipase A2 Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
Edward A. Dennis et al.
CHEMICAL REVIEWS (2011)
Cellular and molecular aspects of vascular dysfunction in systemic sclerosis
Maria Trojanowska
NATURE REVIEWS RHEUMATOLOGY (2010)
Human Parvovirus B19 (B19V) Infection in Systemic Sclerosis Patients
Krystyna Zakrzewska et al.
INTERVIROLOGY (2009)
Induction of Autoimmunity in a Bleomycin-Induced Murine Model of Experimental Systemic Sclerosis: An Important Role for CD4+ T Cells
Hideaki Ishikawa et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Effects of human parvovirus B19 VP1 unique region protein on macrophage responses
Bor-Show Tzang et al.
JOURNAL OF BIOMEDICAL SCIENCE (2009)
Systemic sclerosis and infections
Silvia Bellando Randone et al.
AUTOIMMUNITY REVIEWS (2008)
Interaction of Parvovirus B19 with Human Erythrocytes Alters Virus Structure and Cell Membrane Integrity
Claudia Boensch et al.
JOURNAL OF VIROLOGY (2008)
Conformational changes in the VP1-unique region of native human parvovirus B19 lead to exposure of internal se uences that play a role in virus neutralization and infectivity
Carlos Ros et al.
JOURNAL OF VIROLOGY (2006)
Naturally occurring NF-κB inhibitors
Nguyen-Hai Nam
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2006)
Regulation of PDGF and its receptors in fibrotic diseases
JC Bonner
CYTOKINE & GROWTH FACTOR REVIEWS (2004)
Increased prevalence of human parvovirus B19 DNA in systemic sclerosis skin
T Ohtsuka et al.
BRITISH JOURNAL OF DERMATOLOGY (2004)
Parvoviral infection of endothelial cells and stromal fibroblasts: a possible pathogenetic role in scleroderma
CM Magro et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2004)
Fibrosis in scleroderma
EY Kissin et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2003)
Genome organization of the densovirus from Bombyx mori (BmDNV-1) and enzyme activity of its capsid
Y Li et al.
JOURNAL OF GENERAL VIROLOGY (2001)
Share Paper
